Search research articles
Contact Us
Filters
Showing results (161-170 of 205) with videos related to
Page
of 21
Sort By:
JAMA
|
September 13, 2013
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial
Philippe Mathurin, Alexandre Louvet, Alain Duhamel, et al.
JHEP Reports : Innovation in Hepatology
|
January 1, 2025
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
Jean-Charles Nault, Nanthara Sritharan, Gontran Verset, et al.
Gastroenterology
|
May 4, 2015
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis
Alexandre Louvet, Julien Labreuche, Florent Artru, et al.
Liver Cancer
|
December 15, 2025
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study
François Villeret, Mohamed Bouattour, Jean-Frédéric Blanc, et al.
Hepatology (Baltimore, Md.)
|
December 21, 2020
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension
Laure Elkrief, Marie Lazareth, Sylvie Chevret, et al.
Journal of Hepatology
|
September 18, 2017
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results
Dominique Thabut, Arnaud Pauwels, Nicolas Carbonell, et al.
European Journal of Gastroenterology & Hepatology
|
August 14, 2023
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, et al.
JHEP Reports : Innovation in Hepatology
|
March 19, 2026
Atezolizumab-Bevacizumab in Very Elderly With Hepatocellular Carcinoma: Age Alone Is Not a Limiting Factor Except in ALBI Grade 3
Chloé Métivier, Claudia Campani, Manon Allaire, et al.
Hepatology (Baltimore, Md.)
|
June 18, 2019
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma
Jean-Charles Nault, Yoann Martin, Stefano Caruso, et al.
Journal of Hepatology
|
February 7, 2026
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma
Jean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 205) with videos related to
Sort By:
Page
of 21
JAMA
|
September 13, 2013
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial
Philippe Mathurin, Alexandre Louvet, Alain Duhamel, et al.
JHEP Reports : Innovation in Hepatology
|
January 1, 2025
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
Jean-Charles Nault, Nanthara Sritharan, Gontran Verset, et al.
Gastroenterology
|
May 4, 2015
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis
Alexandre Louvet, Julien Labreuche, Florent Artru, et al.
Liver Cancer
|
December 15, 2025
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study
François Villeret, Mohamed Bouattour, Jean-Frédéric Blanc, et al.
Hepatology (Baltimore, Md.)
|
December 21, 2020
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension
Laure Elkrief, Marie Lazareth, Sylvie Chevret, et al.
Journal of Hepatology
|
September 18, 2017
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results
Dominique Thabut, Arnaud Pauwels, Nicolas Carbonell, et al.
European Journal of Gastroenterology & Hepatology
|
August 14, 2023
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, et al.
JHEP Reports : Innovation in Hepatology
|
March 19, 2026
Atezolizumab-Bevacizumab in Very Elderly With Hepatocellular Carcinoma: Age Alone Is Not a Limiting Factor Except in ALBI Grade 3
Chloé Métivier, Claudia Campani, Manon Allaire, et al.
Hepatology (Baltimore, Md.)
|
June 18, 2019
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma
Jean-Charles Nault, Yoann Martin, Stefano Caruso, et al.
Journal of Hepatology
|
February 7, 2026
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma
Jean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
Page
of 21